Introduction
In 2012, colorectal cancer (CRC) was the third most common cancer in men (746 000 cases) and the second most common in women (614 000 cases); annual mortality exceeds 500 000 (World Health Organization, 2014) . Screening programmes conducted by government agencies slightly differ from one country to another (Benson et al., 2008; European Colorectal Cancer Screening Guidelines Working Group et al., 2013) . However, in most countries, guidelines recommend (a) individualized assessment of risk for CRC in all adults, (b) starting screening at age 50 and in high-risk adults from 40 years and (c) using stool-based tests, flexible sigmoidoscopy or colonoscopy, but always colonoscopy in high-risk individuals (European Colorectal Cancer Screening Guidelines Working Group et al., 2013; US Preventive Services Task Force, 2015) . Screening can be stopped in adults older than 75 years of age.
A minimum uptake is required to ensure screening efficiency, with suggested thresholds ranging from 65 to 75% (National Cancer Institute, 2005 ; European Colorectal Cancer Screening Guidelines Working Group et al., 2013; Holme et al., 2013) . Comparisons between a strategy based on colonoscopy and a strategy based on faecal tests have shown that adherence was higher for screening by faecal test alone (Khalid-de Bakker et al., 2011; Inadomi et al., 2012; Holme et al., 2013) , suggesting that screening should rely on faecal test completion. However, participation rates in countries with organized screening programmes based on faecal tests are low, ranging from 20 to 52%, and with disparities across socioeconomic groups (Gellad et al., 2011) .
In some countries, screening is organized independent of primary care and in others such as in France, policymakers decided that general practitioners (GPs) would be the only providers of faecal immunological test (FIT) kits (French Ministry of Health, 2014) . Factors associated with lower participation rates include female sex, younger participants, lower level of education, lower income, ethnic minorities and being unmarried (Wools et al., 2016) . Identifying reproducible interventions that may be developed in a wider context is essential to maximize the efficacy of CRC screening programmes. Although French authorities have decided to organize FIT kit diffusion through GPs, we wondered whether there was evidence showing the impact of GP involvement on patient uptake and evidence of interventions that increased patient uptake among disadvantaged or hard-to-reach groups. Another issue is the need to compile data on intervention costs to examine the costeffectiveness of the corresponding interventions.
The aim of this review was to investigate the following question: what randomized-controlled trials (RCTs) assessed interventions aiming at increasing uptake of faecal tests for CRC screening in asymptomatic individuals at average risk of CRC?
Methods
This systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (Moher et al., 2015) (Table 1) .
Inclusion and exclusion criteria
The inclusion criteria for the studies included in this review were as follows:
(1) Design: RCT or cluster-RCT. (2) Setting: recruitment in a primary care or community setting, or at population level. (3) Population: asymptomatic adults at average risk of CRC.
Studies were excluded if they had been carried out in high-risk patients; targeted to specific patient groups (such as army veterans); no specification about participants; not reported in peer-reviewed publications; and were not in English or French.
Study identification and selection (Moher et al., 2015) We performed a systematic search of PubMed, Embase and the Cochrane Central Register of Controlled Trials, not limited by dates of publication, on 1 September 2015 (Box 1). We also hand searched reference lists of reviews and studies identified during the initial search. Abstracts and full texts were reviewed independently by two reviewers (C.L. and C.R.) for inclusion. Any disagreements about inclusion or exclusion were resolved by consensus and a third reviewer (A.E.) was consulted to resolve any remaining disagreements. When we identified multiple studies from the same authors investigating the same population or model, we reported them all as one study.
Data extraction
One reviewer (C.L.) extracted data on a form based on the Cochrane data extraction form (Cochrane Wounds Group, 2014) . Studies were critically reviewed by two reviewers (C.L. and C.R.) using the Cochrane Collaboration's risk of bias tool (The Cochrane Collaboration, 2008) , and discrepancies were resolved by consensus.
Data synthesis and assessment of quality
We performed narrative data synthesis, organizing the results by intervention in accordance with previous presentation from other authors (Senore et al., 2015) , depending on whether the intervention focused on information to screening invitees, physician practice or test modalities. Quantitative synthesis was limited by the heterogeneity of the study designs and presentation of results. To ensure consistency when reporting the impact of interventions, we recalculated the number of patients, odds ratios (ORs) and/or P-values when these data were not provided explicitly in the manuscripts. The authors of the article were contacted when the data provided did not allow recalculation of OR and/or P-values. For each study, we analysed the following risks of bias: selection bias, performance bias and detection bias, attrition bias and reporting bias. These biases were classified into three categories (low, moderate, high) according to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols guidelines. We did not assess publication bias.
Results
In total, 275 titles and abstracts were screened for eligibility on the basis of the inclusion and exclusion criteria. Twenty-four studies were included in the review (Fig. 1) .
The main characteristics of the studies are reported in Table 2 . The trials varied in design. Three studies targeted the clinician (GPs) for the interventions, and randomized by clinician (Federici et al., 2005; Aubin-Auger et al., 2014; Tinmouth et al., 2015) . The other 21 studies targeted patients directly with the interventions, and randomized by patient [Myers et al., 1991 [Myers et al., , 2014 Mant et al., 1992; Ore et al., 2001; Vinker et al., 2002; Cole et al., 2003 Cole et al., , 2007 Federici et al., 2005; Hughes et al., 2005; Miller et al., 2005 ; Multicentre Australian Colorectal-neoplasia Screening (MACS) Group, 2006; Gimeno-Garcia et al.,
2009; Lee et al., 2009; Hol et al., 2010; Birkenfeld et al., 2011; Giorgi Rossi et al., 2011; Hewitson et al., 2011; Levi et al., 2011; van Roon et al., 2011; Green et al., 2013; Baker et al., 2014; Neter et al., 2014] . (Table 3 ). Ten studies were based on complex interventions (Myers et al., 1991; Mant et al., 1992; Vinker et al., 2002; Miller et al., 2005; Cole et al., 2007; Hol et al., 2010; Hewitson et al., 2011; Green et al., 2013; Baker et al., 2014; Neter et al., 2014 ), which we report across different categories.
Screening uptakes varied markedly across studies, ranging from 1.2 to 82.2% (Table 3) . In seven studies, the uptake in the control group was less than 20%; in 12 studies, it ranged from 20 to 40%; in seven studies, it ranged from 40 to 60%; and in three, it was over 60%. Screening uptake assessments were performed after various periods, ranging from 2 weeks to 24 months (Table 2) . In nine studies, screening uptake was assessed before 6 months; in five studies, it was performed between 6 months and 1 year; and in one, it was performed at 12 and 24 months.
Heterogeneous interventions Faecal immunological test versus guaiac faecal occult blood test
Six studies compared the use of FIT versus gFOBT kits (Cole et al., 2003; Federici et al., 2005; Hughes et al., 2005; Hol et al., 2010; Birkenfeld et al., 2011; Levi et al., 2011) . Four concluded that using FIT rather than gFOBT significantly increased uptake of screening tests [95% confidence interval (CI) = 1.29-2.14] (Cole et al., 2003; Federici et al., 2005; Hughes et al., 2005; Hol et al., 2010) . In contrast, two studies based on large samples (16 132 and 12 537 individuals) found that gFOBT was associated with higher uptake (OR = 0.86 and 0.92) Levi et al., 2011) .
Advanced notification letter
Two studies reported the positive impact of an advanced notification letter (Cole et al., 2007; van Roon et al., 2011) .
They assessed the impact of mailing an information letter before the standard invitation, aiming to raise awareness of CRC screening among eligible individuals (95% CI = 1.20-1.51). A third study also reported higher uptake after an advanced notification letter (31.7 vs. 25.5%), but the difference was not statistically significant (P = 0.051) (Mant et al., 1992) .
Postal mailing of kits
Five studies reported that mailing kits to screening invitees increased uptake (95% CI = 1.30-2.89) (Mant 
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Copyright r 2018 Wolters Kluwer Health, Inc. All rights reserved. , 1992; Ore et al., 2001; Giorgi Rossi et al., 2011; Green et al., 2013; Tinmouth et al., 2015) . Four of these studies compared a direct mailing of the kit versus a standard letter with an invitation to collect a kit in a primary care clinic (Mant et al., 1992; Ore et al., 2001; Giorgi Rossi et al., 2011; Green et al., 2013) . The fifth study focused on nonrespondents to an initial mailed invitation (Tinmouth et al., 2015) .
Frames of invitation messages
Five studies assessed the effect of different frames of invitation messages (varying presentation and content of the written information) [Myers et al., 1991 ; Multicentre Australian Colorectal-neoplasia Screening (MACS) Group, 2006; Cole et al., 2007; Hewitson et al., 2011; Neter et al., 2014] . Three showed increases in uptake, on the basis of a leaflet containing information on faecal occult blood test (FOBT) (Hewitson et al., 2011) , an 'implementation intention' technique (Neter et al., 2014) or letting the participant choose between different screening tests (FOBT, colonoscopy, sigmoidoscopy or computed tomography colonography) [Multicentre Australian Colorectal-neoplasia Screening (MACS) Group, 2006] . Two found no statistically significant effect: one compared gain or loss framed messages in booklets sent with invitation letters (Myers et al., 1991) ; the other evaluated an intervention to enhance awareness of the risk of CRC on the basis of advocacy messages (Cole et al., 2007) .
Reminders
Three studies showed increased uptake ranging from 15.6 to 47.1% (95% CI = 1.31-7.70) on the basis of telephone and written reminders (Myers et al., 1991; Green et al., 2013; Baker et al., 2014) .
Tailored navigation
Four studies showed increased uptake following a 'navigation intervention' on the basis of telephone calls by a counsellor (95% CI = 1.36-7.72) (Myers et al., 1991; Green et al., 2013) . In two or three arm RCTs, interventions included an instruction call to patients within a week after kit mailing (telephone call about how to perform the test), a reminder phone call at 30 days if no tests were returned (Myers et al., 1991) ; telephone assistance with a navigator after postal mailing of kits and mailed reminder letters (Green et al., 2013; Baker et al., 2014) ; and a personal navigator call to review mailed materials and explore preferences and barriers for screening (Myers et al., 2014) .
Video-based or computer-based interventions
Two studies assessed video-based or computer-based interventions. One reported a slight improvement of test uptake within 2 weeks after a video-based educational intervention (69.9 vs. 54.4%, P = 0.044) (Miller et al., 2005) . The second compared the effect of counselling provided by automatized informatics software with counselling by a
One month later the nonresponders received a follow-up reminder using the same method (the fourth arm if a control group was included).
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nurse (Miller et al., 2005) , without showing any impact on uptake of screening tests (62 vs. 63%).
Improving general practitioner involvement
Finally, three studies reported interventions requiring GP involvement. Two showed increased uptake -from 12.2 to 15.3% (each statistically significant) (Vinker et al., 2002 ; Aubin-Auger et al., 2014) -whereas one was inconclusive (Hewitson et al., 2011) . Aubin-Auger et al. (2014) reported the impact of GP training focused on communication skills [increased screening uptake in the intervention arm (36.7 vs. 24.5%; P = 0.03)]. Vinker et al. (2002) reported the impact of mailing reminders to GPs, rather than sending reminders to screening participants (OR =14.8).
Focus on nonresponders and disadvantaged groups
One study focused on nonresponders (Tinmouth et al., 2015) . Six authors reported that a higher socioeconomic status was associated with a higher uptake of screening test (Cole et al., 2003; Hol et al., 2010; Birkenfeld et al., 2011; Levi et al., 2011; van Roon et al., 2011; Neter et al., 2014) . However, none of them reported a specific impact of the experimented intervention on screening uptake inequalities in the corresponding populations. None of the studies assessed targeted interventions aiming to improve participation in disadvantaged groups.
Intervention costs
Costs related to the intervention were reported in 4 studies, but there were wide variations in the data provided. Giorgi Rossi et al. (2011) assessed the cost of mailing FOBT (from €4.24 to €46.80, depending on whether the patient was a responder or not). The cost of performing a standard recall ranged from €3.29 to €18.30 (depending on whether the patient was a responder or not). Baker et al. (2014) evaluated the cost per completed test at $43.13 on the basis of a complex intervention with mailing, automated call and text message. Green et al. (2013) reported costs ranging from $371 to $557 for interventions on the basis of assisted care or navigated group.
Discussion Principal findings
From 24 randomized-controlled studies, the following interventions increased uptake of faecal tests for CRC screening: advance notification letter (Cole et al., 2007; van Roon et al., 2011) , postal mailing (Mant et al., 1992; Ore et al., 2001; Giorgi Rossi et al., 2011; Green et al., 2013; Tinmouth et al., 2015) , written reminders [Myers et al., 1991 ; Multicentre Australian Colorectal-neoplasia Screening (MACS) Group, 2006] and telephone contacts with a navigator or a medical assistant (Myers et al., 1991 (Myers et al., , 2014 Green et al., 2013; Baker et al., 2014) . Three interventions showed positive effects of GP involvement (Vinker et al., 2002; Hewitson et al., 2011 ; Aubin-Auger et al., 2014) using a GP-signed invitation letter, GP communication training or mailed reminders to GPs. Other studies assessed whether patient counselling could be provided by video or using automatized informatics software (Miller et al., 2005; Gimeno-Garcia et al., 2009) . Heterogeneous results were found for studies comparing FIT versus FOBT, and those testing effectiveness of different formats of written information. None of the interventions targeted participation in disadvantaged groups. Only one focused on nonresponders (Tinmouth et al., 2015) .
Strengths and weaknesses
Quality of the evidence
General evaluation showed risks of bias for most studies. None of the studies was blinded. Loss-to-follow-up and randomization were frequently unclear -reported in only eight studies [Ore et al., 2001; Miller et al., 2005;  Multicentre Australian Colorectal-neoplasia Screening (MACS) Group, 2006; Lee et al., 2009; Levi et al., 2011; van Roon et al., 2011; Green et al., 2013; Aubin-Auger et al., 2014] . Only nine studies reported a power calculation [Cole et al., 2003; Federici et al., 2005; Miller et al., 2005 ; Multicentre Australian Colorectal-neoplasia Screening (MACS) Group, 2006; Gimeno-Garcia et al., 2009; Hol et al., 2010; Hewitson et al., 2011; van Roon et al., 2011; Aubin-Auger et al., 2014] . Selective reporting was estimated as moderate or high risk for six studies (Mant et al., 1992; Ore et al., 2001; Vinker et al., 2002; Cole et al., 2007; Gimeno-Garcia et al., 2009; Birkenfeld et al., 2011) . Funding source was missing in eight studies (Myers et al., 1991; Mant et al., 1992; Federici et al., 2005; Birkenfeld et al., 2011; Hewitson et al., 2011; Levi et al., 2011; Baker et al., 2014; Neter et al., 2014) .
Most studies focused on an average-risk population aged from 50 to 74 years. Five studies included populations defined by other age thresholds [Mant et al., 1992;  Multicentre Australian Colorectal-neoplasia Screening (MACS) Group, 2006; Cole et al., 2007; Lee et al., 2009; Hewitson et al., 2011 ] -such as 45-64 years (Mant et al., 1992) or 60-75 years (Lee et al., 2009) , but the related reasons were not provided.
The studies that assessed the effectiveness of different formats of written information assessed very different interventions so that considering them separately in further studies would probably be more appropriate.
Potential biases in the review process
The grey literature was not searched, potentially leading to publication bias. Interventions leading to null results are less likely to have been accepted for publication; thus, the review may overestimate apparent intervention effects.
Comparison with other studies
From observational studies, Vart et al. (2012) reported FIT characteristics that might improve CRC screening uptake: simplicity of tests, absence of dietary restrictions, less stool manipulation and simplified procedures for analysis. Their meta-analysis also supported higher uptake rates in the FIT group. Both Vart et al.'s (2012) and our review found greater uptake with FIT tests for studies in the earlier period (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) . However, two recent studies Levi et al., 2011) did not confirm this increase in screening uptake on the basis of the use of FIT. A suggestion might be to give priority to a communication on FIT on the basis of its higher efficacy, rather than communicating on the increase in patient uptake. For stool DNA tests, previous authors reported that patients would prefer DNA tests to colonoscopy (Abola et al., 2015; Cole et al., 2015) , but we did not find studies comparing FIT and DNA tests and effects on test uptake. A recent publication from Berger et al. (2016) reported a very high participation rate with stool DNA tests (99%), but they did not discuss the selection bias.
This review provides evidence that various interventions increase test uptake and could be easily implemented: advance notification letter, postal mailing of screening tests and written reminders. These results are consistent with the findings of previous reviews that included RCTs, but also observational, cross-sectional, experimental and before and after studies (Sabatino et al., 2008; Camilloni et al., 2013; Senore et al., 2015) . Camilloni et al. (2013) also concluded that postal and telephone reminders, mailed invitation letters signed by GPs, scheduled appointments and mailing kits to nonresponders were effective interventions. Similarly, Sabatino et al. (2008) reviewed 11 interventions to increase screening for cervical, breast and colon cancers. They reported that one-to-one education and reminders improve uptake rates for CRC screening tests.
Telephone contacts and the involvement of navigators also led to higher uptake of screening tests, but these are more resource-intensive and may be difficult to implement in the usual screening setting. These results are consistent with the conclusions of Naylor et al. (2012) , who focused on interventions that decrease racial and ethnic disparities towards CRC care and prevention. Naylor et al. (2012) included 33 studies targeting AfricanAmerican, Hispanic and other minorities' individuals. Navigation interventions -including specific elements such as language-adapted education materials in complex interventions -increased CRC screening uptake in these specific populations. However, all these interventions require recruiting navigators, training and making them available in the routine healthcare setting, and there is limited generalizable evidence for the entire population at average risk of CRC (Senore et al., 2015) . Moreover, our focus on the costs associated with such interventions show that they would be associated with a multiplication of the costs (from €4 to €500/completed test).
Further interventions could involve video-based or computer-based information. However, such information modalities might not be sufficient to convince individuals who are not concerned about CRC risk to consider screening. The positive effect observed for these interventions might also be because of a selection bias (Table 2 ).
There was limited evidence that training GPs is effective. Senore et al. (2015) suggested that providing feedback to providers about their screening rates may reinforce their commitment to promote screening. However, the original research leading to this statement was a 'before versus after' study carried out among resident physicians from 1993 to 1995 (Goebel, 1997) ; thus, further research would be required to generalize these findings to private practice or other settings. Development of specific communication skills may be effective, but implementing changes in everyday practice after formal continuing medical education is difficult. In terms of communication-based interventions direct to patients, they can be effective for chronic disease management, but there are difficulties in modifying preventive behaviours (Hilberink et al., 2011; Butler et al., 2013; Mehring et al., 2014) . It may be hypothesized that GPs could enhance screening uptake on the basis of their long-term relationships with patients. However, there is a lack of well-designed trials involving GPs, whereas such studies could focus on barriers to test uptake. Quintero et al., 2012) . On the other, provided that high levels of attendance would be obtained at the first-level uptake, it is mandatory to convince participants selected on the basis of a positive faecal test to undergo the diagnostic phase. In several programmes worldwide, compliance with the second-level phase of screening is not satisfactory (Chopra and Hookey, 2016; Plumb et al., 2016) . Recent publications suggested that patients might prefer computed tomography colonography (Pooler et al., 2012; Gareen et al., 2015) . In total, there is no evidence that one strategy would lead to better uptake (Ghanouni et al., 2014) . Comparison of test uptake is difficult because recommended intervals between tests are very different depending on the test itself (Levin et al., 2008; Rex et al., 2009) . Holme et al. (2013) studied flexible sigmoidoscopy attendance: at the population level, attendance rates were estimated at 38 and 10% in two studies (Segnan et al., 2005; Atkin et al., 2010) , whereas a third study estimated it to be between 0.3 and 3.4% (Simpson et al., 2000) . In total, Multicentre Australian Colorectal-neoplasia Screening (MACS) Group (2006) and Senore et al. (2015) concluded that offering individuals the option to choose between flexible sigmoidoscopy and FIT did not improve uptake.
Conclusion
Advance notification letters, postal mailing of the kits, written reminders and telephone contacts with an advisor increase patient uptake of faecal tests. There is limited evidence of the effect of GP involvement on screening test uptake, and a lack of studies focusing on nonresponders or disadvantaged groups.
